This document discusses Optum winning the 2018 North American Population Health Management Company of the Year Award. It outlines the challenges in population health management, and how Optum addresses these challenges through its integrated approach leveraging advanced analytics, care coordination, quality reporting, and clinical programs. Optum provides superior capabilities in quality/clinical integration, risk stratification, provider network management, care coordination, and patient engagement to advance cost-effective population health management.
ExecutiveInsight July 2014 - Supply Chain cover storygaryjohnson500
The document discusses strategies for optimizing healthcare supply chain management. It notes that simply relying on group purchasing organizations for lower prices is no longer sufficient, and health systems are now looking more closely at cost variability, utilization, and quality across hospitals, units, and clinicians. Advanced analytics and improved value analysis processes are helping to generate savings. However, fully optimizing supply chain management requires accountability across the entire health system to improve processes and focus on patient outcomes. Automating supply chain processes can also reduce waste compared to current manual methods. Coordinating all facets of vendor management through a streamlined supply chain is key to generating savings from this area, which accounts for up to half of total healthcare costs.
Data-driven Healthcare for the Pharmaceutical IndustryLindaWatson19
The tremendous opportunity of a data-driven strategy is apparent to the pharmaceutical industry, as all these informational assets exhibiting volume, variety, and velocity need to be ingested and analyzed for enhanced insight leading to better business decisions to address proactively the needs of patient care, while getting to market cheaper, faster, with better products.
From Social Media through to Artificial intelligence...and more. In this presentation I covered the trends that we're currently seeing in Medical Affairs - those trends which are important now, those trends which will impact Medical Affairs in the future, and the skills required to be successful.
To read the LinkedIn article here’s the link: https://www.linkedin.com/pulse/trends-medical-affairs-presented-appa-march-14-2018-glenn-carter/
For further discussion phone us on:
Sydney (02) 8877 8777
Melbourne (03) 9938 7100
Or for additional insights go to one of our specialised websites:
Healthcare Professionals Group
(https://www.hpgconnect.com/)
Health & Aged Care Professionals (https://www.hacpconnect.com/)
Pharmaceutical & Medical Professionals
(https://www.pmpconnect.com/)
Rural & Remote Healthcare Professionals
(https://www.rrhpconnect.com/)
Elevating the Health of Healthcare: A Four Step GuideIntalere
This white paper outlines a four step guide for healthcare providers to elevate their operational health: 1) seek customized solutions tailored to their unique needs and challenges; 2) effectively manage their non-labor spend, which accounts for up to 50% of costs; 3) leverage innovative technologies, products, and services; and 4) adopt best practices from successful provider-led models. The paper provides examples of how partnerships with experienced organizations have helped providers implement these steps to significantly reduce costs while maintaining or improving care.
This document discusses how hospital supply chains can transform from basic models focused on operations to more advanced models that balance costs, efficiency, and quality of care. It identifies three key enablers of transformation: collaborative governance structures involving clinicians, streamlined supply chain processes, and integrated IT systems. A case study highlights how one healthcare system achieved cost savings through strategic sourcing, a distribution center, and technology like barcoding medications.
This presentation gives an insight into the membership benefits of Best Practices, LLC’s Medical Affairs Consortium. It also highlights some of the key benchmarks and best practices that emerged from Medical Affairs Consortium.
The Medical Affairs Consortium at Best Practices, LLC provides a dedicated platform to Medical Affairs Leaders to discuss top challenges, develop action oriented solutions, share best practices & lessons learned and explore current and future trends with regards to the Medical Affairs function and its interactions with other critical functions.
Topics for the Medical Affairs Consortium are usually determined by member requests. The Medical Affairs Consortium addresses three key areas:
• Building Strong Medical Affairs Capabilities
• Medical Affairs Launch Support Excellence
• Medical Affairs’ Critical Role in Health Economics & Outcomes Research
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Best Practices
The Medical Affairs function plays an important role in health outcomes (HO) information exchange between bio-pharmaceutical organizations and key external stakeholders.
Development of robust health outcomes capabilities within Medical Affairs function requires an increase in the function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data as per stakeholders’ needs, and building real world data capabilities to generate and utilize health outcomes information.
This benchmarking research from Best Practices, LLC is designed to assist companies focused on oncology therapies find better ways to develop effective health outcomes groups. It provides current data and best practices from Medical Affairs leaders with an oncology focus at leading bio-pharmaceutical companies.
Download Full Report: http://bit.ly/2e3sl9Q
ExecutiveInsight July 2014 - Supply Chain cover storygaryjohnson500
The document discusses strategies for optimizing healthcare supply chain management. It notes that simply relying on group purchasing organizations for lower prices is no longer sufficient, and health systems are now looking more closely at cost variability, utilization, and quality across hospitals, units, and clinicians. Advanced analytics and improved value analysis processes are helping to generate savings. However, fully optimizing supply chain management requires accountability across the entire health system to improve processes and focus on patient outcomes. Automating supply chain processes can also reduce waste compared to current manual methods. Coordinating all facets of vendor management through a streamlined supply chain is key to generating savings from this area, which accounts for up to half of total healthcare costs.
Data-driven Healthcare for the Pharmaceutical IndustryLindaWatson19
The tremendous opportunity of a data-driven strategy is apparent to the pharmaceutical industry, as all these informational assets exhibiting volume, variety, and velocity need to be ingested and analyzed for enhanced insight leading to better business decisions to address proactively the needs of patient care, while getting to market cheaper, faster, with better products.
From Social Media through to Artificial intelligence...and more. In this presentation I covered the trends that we're currently seeing in Medical Affairs - those trends which are important now, those trends which will impact Medical Affairs in the future, and the skills required to be successful.
To read the LinkedIn article here’s the link: https://www.linkedin.com/pulse/trends-medical-affairs-presented-appa-march-14-2018-glenn-carter/
For further discussion phone us on:
Sydney (02) 8877 8777
Melbourne (03) 9938 7100
Or for additional insights go to one of our specialised websites:
Healthcare Professionals Group
(https://www.hpgconnect.com/)
Health & Aged Care Professionals (https://www.hacpconnect.com/)
Pharmaceutical & Medical Professionals
(https://www.pmpconnect.com/)
Rural & Remote Healthcare Professionals
(https://www.rrhpconnect.com/)
Elevating the Health of Healthcare: A Four Step GuideIntalere
This white paper outlines a four step guide for healthcare providers to elevate their operational health: 1) seek customized solutions tailored to their unique needs and challenges; 2) effectively manage their non-labor spend, which accounts for up to 50% of costs; 3) leverage innovative technologies, products, and services; and 4) adopt best practices from successful provider-led models. The paper provides examples of how partnerships with experienced organizations have helped providers implement these steps to significantly reduce costs while maintaining or improving care.
This document discusses how hospital supply chains can transform from basic models focused on operations to more advanced models that balance costs, efficiency, and quality of care. It identifies three key enablers of transformation: collaborative governance structures involving clinicians, streamlined supply chain processes, and integrated IT systems. A case study highlights how one healthcare system achieved cost savings through strategic sourcing, a distribution center, and technology like barcoding medications.
This presentation gives an insight into the membership benefits of Best Practices, LLC’s Medical Affairs Consortium. It also highlights some of the key benchmarks and best practices that emerged from Medical Affairs Consortium.
The Medical Affairs Consortium at Best Practices, LLC provides a dedicated platform to Medical Affairs Leaders to discuss top challenges, develop action oriented solutions, share best practices & lessons learned and explore current and future trends with regards to the Medical Affairs function and its interactions with other critical functions.
Topics for the Medical Affairs Consortium are usually determined by member requests. The Medical Affairs Consortium addresses three key areas:
• Building Strong Medical Affairs Capabilities
• Medical Affairs Launch Support Excellence
• Medical Affairs’ Critical Role in Health Economics & Outcomes Research
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Best Practices
The Medical Affairs function plays an important role in health outcomes (HO) information exchange between bio-pharmaceutical organizations and key external stakeholders.
Development of robust health outcomes capabilities within Medical Affairs function requires an increase in the function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data as per stakeholders’ needs, and building real world data capabilities to generate and utilize health outcomes information.
This benchmarking research from Best Practices, LLC is designed to assist companies focused on oncology therapies find better ways to develop effective health outcomes groups. It provides current data and best practices from Medical Affairs leaders with an oncology focus at leading bio-pharmaceutical companies.
Download Full Report: http://bit.ly/2e3sl9Q
The document provides an overview of Edgewater Technology, a strategic technology management consulting firm focused on the healthcare industry. It describes Edgewater's background, services, industry experience, and case studies working with healthcare organizations to implement enterprise data strategies, data warehouses, business intelligence solutions, and other technologies. Key goals for healthcare clients included improving patient outcomes, increasing efficiency and compliance through data-driven insights.
Modernizing physician alignment strategies requires understanding physician behavior through data analytics to better modify and track performance, improve referral rates, and align physicians with the healthcare institution's goals in order to impact financial performance and compete in today's changing healthcare landscape. Sophisticated physician relationship management systems provide a 360-degree view of physician loyalty and activity across specialties using integrated healthcare claims data to facilitate meaningful dialogue between physicians and the institution.
Medical Affairs Leadership Summit, Key APAC Insights - August 2016Lynn Okamoto
1) The document summarizes insights from a medical affairs leadership summit in Asia Pacific that discussed defining medical affairs visions and missions, transforming field medical teams, the role of medical affairs in late-stage development and launch readiness.
2) Key topics included adapting medical affairs visions to evolving healthcare landscapes, enhancing field teams' business skills and ability to generate insights, challenges generating real-world evidence in diverse Asia Pacific markets, and ensuring adequate planning and resources for medical affairs involvement in launches.
3) Attendees discussed how medical affairs can demonstrate greater strategic value by engaging more stakeholders, generating regional insights, and involving earlier in product development and launches.
This document discusses Quality Systems, Inc. and its subsidiary NextGen Healthcare Information Systems. It provides an overview of the company's business, markets served, products, growth strategy, financial performance, management team, and competitive advantages in the healthcare information technology industry. Key points include Quality Systems' focus on developing practice management and electronic health record software, its track record of strong revenue and earnings growth, experienced management team, and positioning to benefit from positive industry trends driven by government initiatives.
Medical Affairs, as a function, sits at a crossroads in the pharmaceutical industry. The department is expected to act as a bridge between the commercial and scientific arms of an organization. Medical Affairs is further tasked with being the conduit of information between the company and external stakeholders, bringing efficacy and safety data to the medical community as well as gathering insights from the medical community to share internally. All responsibilities must be undertaken while keeping in mind strict regulatory controls and ensuring that medical data are interpreted appropriately.
ISR has designed this report to be used as a benchmarking tool for companies to compare their Medical Affairs functions to those of Top 50 pharmaceutical organizations.
See more: http://bit.ly/medaffairs
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...Best Practices
With the shift toward evidence-based medicine and value-based pricing, many bio-pharmaceutical companies are transitioning their Health Economics and Outcomes Research (HEOR) function away from the Commercial organization to Medical Affairs. This has some major implications towards the interactions with key stakeholders, the way interactions are documented and the skill sets & activities that may be required. Development of strong health outcomes capabilities within Medical Affairs organizations requires an increase in that function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data by stakeholders and building real world data capabilities to generate and utilize health outcomes information.
Best Practices, LLC undertook this study to identify strategies to increase MA’s role in Health Outcomes data generation and utilization. Specifically, the study highlights the role of Medical Affairs function in HO activities, industry drivers and resource levels for HO groups, challenges of MA’s involvement in HO activities and strategies for effective HO data communication and utilization.
Download Full Report: http://bit.ly/2dGFAbz
Historically, the medical device industry has been highly attractive and relatively stable. As a consequence, established players have been able to compete successfully across the device spectrum, applying common business models and processes without much need for differentiation.
The future, however, is very different as disruptive change is underway. Companies will need to look at new segments and offer end-to-end solutions to secure additional revenue and maintain their profit margins.
The document discusses opportunities and challenges for GSK's marketing strategy due to various political, economic, social and technological factors. It analyzes GSK's strengths like focus on R&D and parent synergy, as well as weaknesses like limited liquidity position. Opportunities discussed are launch of new products and growth in healthcare markets like India. Threats include uncertain R&D outcomes and government regulations. The document also discusses trends reshaping the healthcare industry like empowered patients and use of real-world data. Major changes in digital health are driving new opportunities for pharma companies.
The healthcare industry in India is facing a complex, competitive environment driven by disruptive technology. For healthcare organizations to survive, data-driven management is needed. As payment reforms increase pressure to improve quality while lowering costs, some hospitals have adopted quality improvement methodologies from other industries, like data analytics. Experts believe healthcare providers that invest in analytics through partnerships will have success. The article outlines the types of data analytics used in healthcare - descriptive analytics of past data, predictive analytics to forecast future needs, and prescriptive analytics to provide recommendations. It also discusses challenges to implementing data-driven management and provides steps for healthcare organizations to become more data-driven.
This document discusses how life sciences companies can address challenges in the industry by adopting new technologies. It identifies trends putting pressure on companies, such as new regulations and shifting customer expectations. It then presents solutions that technology can provide: a new multi-channel commercial model to better engage customers; business agility through cloud-based platforms to accelerate innovation; and a focus on outcomes through data analytics and patient services to improve care. Adopting modern cloud technologies, the document argues, is key for companies to transform their business models and adapt to changes in the industry environment.
Providers need to move towards real-time analytics that have become critical to demonstrate their quality of care, as reimbursement by government programs can be contingent upon how providers are measured in “Quality of Care”. For example, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, also called the Permanent Doc Fix, changes the way Medicare doctors are reimbursed with the implementation of a merit based incentive. The performance-based pressure is huge, which makes it imperative that every provider consider technology solutions. Read more at https://www.solix.com/solutions/data-driven-solutions/healthcare/
This document provides an overview of Synergetics' "Industry in Focus" series highlighting trends in the healthcare and life sciences industry and how Synergetics is positioned to help clients in this sector. It discusses the challenges facing third party administrators in healthcare, including balancing costs and provider reimbursement rates. It also identifies factors driving increasing healthcare costs and provides examples of ways Synergetics has helped healthcare clients improve efficiency and profitability through process improvements and technology optimization.
Healthcare ito in healthcare payer - annual report - preview deck - july 2013Everest Group
This report provides an overview of the ITO market for the healthcare payer industry. Analysis includes key trends in market size & growth, demand drivers, adoption & scope trends, emerging themes, key areas of investment, and implications for key stakeholders. The report also provides specific updates on the readiness of the various stakeholders from the perspective of payer reform mandates
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiTTC, llc
The document discusses current challenges and future trends in clinical development from the perspective of a CRO. It notes that the global CRO market is large but fragmented, and outlines pressures on the pharmaceutical industry like high R&D costs, patent expirations, and regulatory demands. The text also examines trends towards more global, efficient trials using new technologies and less traditional geographies to address these challenges. It argues that collaboration between industry, regulators and CROs will be key to transforming clinical research methods.
In recent years, medical device manufacturers have embarked on an acquisition binge. We’ve seen a series of blockbuster deals as well as numerous smaller transactions. This M&A bonanza has been sparked in part by the belief that absolute scale creates competitive advantage.
But does it? In many other industries, we find a clear correlation between overall scale and profitability. Classic strategy has long focused on building scale because larger companies tend to wield more influence with customers and have a greater ability to maintain pricing discipline. They also benefit from the most accumulated experience with driving down costs and can spread costs over the widest base of business.
Yet in medtech, the correlation between industry scale and profitability is quite weak. Instead, Bain research shows that profitability is more a function of category leadership than overall scale.
Strategic Medical Affairs in pharma and medical devicesAnjan Banerjee
Strategic medical affairs in pharma and medical devices outlines key drivers influencing the growing role of medical affairs functions. Regulatory requirements, demand for local excellence, and the need for transparency are pushing medical activities to expand in areas like medical strategy, clinical operations, and regulatory submissions. Medical affairs contributes throughout the product lifecycle by collecting and disseminating knowledge to internal and external audiences, and can help integrate products into healthcare systems from drug development to reimbursement.
United States life sciences companies face numerous challenges in 2015 related to market changes, consolidation, pricing pressures, and health reform. Six key issues are highlighted: 1) Market reconfiguration and consolidation due to factors like expiring patents are driving the need for companies to reassess strategies and explore M&A opportunities. 2) Pricing pressures exist from government efforts to control costs and from health plans increasing efforts to reduce pharmaceutical costs. 3) Health reform is shifting the market to value-based care, requiring companies to demonstrate drugs' and devices' true value and economic impact compared to alternatives.
This document summarizes the key findings of a 2005 survey on healthcare supply chain management conducted by HFMA. The survey identified areas of high opportunity to reduce costs, including physician/clinical buy-in, IT investments, and value analysis. Respondents estimated they could reduce supply costs by an additional 2.5% annually by focusing on standardizing items and improving purchasing controls and physician involvement. While most hospitals have standardization initiatives, physician awareness remains low. The document discusses strategies for improving physician buy-in, such as ensuring transparency and a process for evaluating new products.
The Foundations of Success in Population Health ManagementHealth Catalyst
From hospital systems to large employers, organizations are increasingly taking on financial risk for the health of populations. Drivers of this trend include the update to the MSSP model, the recent CMS Primary Cares Initiative announcement, the increasing prevalence of the Medicare Advantage model, innovative partnerships in the self-insured employer space, and the proliferation of Medicaid ACOs. Yet while market pressures push organizations toward population risk, they don't necessarily help them succeed: most organizations are struggling to attain or sustain the dual imperatives of high-quality care and cost containment. A primary reason? Short-sighted and tactical approaches that don't provide the flexible data infrastructure and tools to adapt to emerging trends in population health—or to support short-term contractual requirements while building toward long-term success.
View this launch webinar to learn about Health Catalyst’s Population Health Foundations solution, a data and analytics-first starter set aimed at optimizing performance in value-based risk arrangements and providing the data ecosystem that will flex and adapt to complex needs of risk-bearing organizations. Solution services ensure that the strategic value of data is maximized to improve performance in risk contracts—and provide side-by-side subject matter expert partnership for establishing short- and long-term goals for population health management (PHM).
Built on Health Catalyst’s foundational technology and supported by the nationwide experience and perspective of its experts, the Population Health Foundations solution helps organizations leverage multiple data sources to understand their patient populations and create meaningful views of financial and clinical quality performance. As a starter set that organizations can build on based on their needs, the solution is designed to compensate for the known limitations of “black box” population health applications that fail to reveal the “why” of analytic insights and exacerbate the challenges of transforming quality, cost, and care. The Population Health Foundations solution delivers the essential analytic tools needed for success under value-based risk arrangements.
In these slides you can expect to:
- Review recent changes to the field of value-based care, and reactions and insights from the market
- Discover how the Population Health Foundations solution can act as a comprehensive, data-first analytics solution to support your population stratification and monitoring needs
- Understand how this solution functions as a foundational starter set for value-based care success, enabling clients to leverage all their data and other relevant population health tools
The document discusses a technology company called SA Ignite that provides software solutions to help healthcare organizations comply with value-based care programs. It describes the challenges providers face with new programs like MIPS that tie Medicare reimbursements to quality metrics. SA Ignite's platform automates and simplifies tracking, measuring, and reporting on clinical and financial performance required by these programs. The platform provides end-to-end support through predictive analytics and expert guidance, helping organizations adapt to the shift toward value-based care.
Life Sciences: Leveraging Customer Data for Commercial SuccessCognizant
The document discusses how life sciences companies need to leverage customer data through master data management solutions in order to succeed commercially in an evolving healthcare landscape. It describes how the healthcare buying process has become more complex with new stakeholders influencing decisions. An effective customer data strategy is critical for life sciences companies to maintain a 360-degree view of customers and address the changing dynamics. This requires solutions that consolidate data from multiple sources to provide insights that can optimize commercial activities like marketing and sales.
The document provides an overview of Edgewater Technology, a strategic technology management consulting firm focused on the healthcare industry. It describes Edgewater's background, services, industry experience, and case studies working with healthcare organizations to implement enterprise data strategies, data warehouses, business intelligence solutions, and other technologies. Key goals for healthcare clients included improving patient outcomes, increasing efficiency and compliance through data-driven insights.
Modernizing physician alignment strategies requires understanding physician behavior through data analytics to better modify and track performance, improve referral rates, and align physicians with the healthcare institution's goals in order to impact financial performance and compete in today's changing healthcare landscape. Sophisticated physician relationship management systems provide a 360-degree view of physician loyalty and activity across specialties using integrated healthcare claims data to facilitate meaningful dialogue between physicians and the institution.
Medical Affairs Leadership Summit, Key APAC Insights - August 2016Lynn Okamoto
1) The document summarizes insights from a medical affairs leadership summit in Asia Pacific that discussed defining medical affairs visions and missions, transforming field medical teams, the role of medical affairs in late-stage development and launch readiness.
2) Key topics included adapting medical affairs visions to evolving healthcare landscapes, enhancing field teams' business skills and ability to generate insights, challenges generating real-world evidence in diverse Asia Pacific markets, and ensuring adequate planning and resources for medical affairs involvement in launches.
3) Attendees discussed how medical affairs can demonstrate greater strategic value by engaging more stakeholders, generating regional insights, and involving earlier in product development and launches.
This document discusses Quality Systems, Inc. and its subsidiary NextGen Healthcare Information Systems. It provides an overview of the company's business, markets served, products, growth strategy, financial performance, management team, and competitive advantages in the healthcare information technology industry. Key points include Quality Systems' focus on developing practice management and electronic health record software, its track record of strong revenue and earnings growth, experienced management team, and positioning to benefit from positive industry trends driven by government initiatives.
Medical Affairs, as a function, sits at a crossroads in the pharmaceutical industry. The department is expected to act as a bridge between the commercial and scientific arms of an organization. Medical Affairs is further tasked with being the conduit of information between the company and external stakeholders, bringing efficacy and safety data to the medical community as well as gathering insights from the medical community to share internally. All responsibilities must be undertaken while keeping in mind strict regulatory controls and ensuring that medical data are interpreted appropriately.
ISR has designed this report to be used as a benchmarking tool for companies to compare their Medical Affairs functions to those of Top 50 pharmaceutical organizations.
See more: http://bit.ly/medaffairs
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...Best Practices
With the shift toward evidence-based medicine and value-based pricing, many bio-pharmaceutical companies are transitioning their Health Economics and Outcomes Research (HEOR) function away from the Commercial organization to Medical Affairs. This has some major implications towards the interactions with key stakeholders, the way interactions are documented and the skill sets & activities that may be required. Development of strong health outcomes capabilities within Medical Affairs organizations requires an increase in that function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data by stakeholders and building real world data capabilities to generate and utilize health outcomes information.
Best Practices, LLC undertook this study to identify strategies to increase MA’s role in Health Outcomes data generation and utilization. Specifically, the study highlights the role of Medical Affairs function in HO activities, industry drivers and resource levels for HO groups, challenges of MA’s involvement in HO activities and strategies for effective HO data communication and utilization.
Download Full Report: http://bit.ly/2dGFAbz
Historically, the medical device industry has been highly attractive and relatively stable. As a consequence, established players have been able to compete successfully across the device spectrum, applying common business models and processes without much need for differentiation.
The future, however, is very different as disruptive change is underway. Companies will need to look at new segments and offer end-to-end solutions to secure additional revenue and maintain their profit margins.
The document discusses opportunities and challenges for GSK's marketing strategy due to various political, economic, social and technological factors. It analyzes GSK's strengths like focus on R&D and parent synergy, as well as weaknesses like limited liquidity position. Opportunities discussed are launch of new products and growth in healthcare markets like India. Threats include uncertain R&D outcomes and government regulations. The document also discusses trends reshaping the healthcare industry like empowered patients and use of real-world data. Major changes in digital health are driving new opportunities for pharma companies.
The healthcare industry in India is facing a complex, competitive environment driven by disruptive technology. For healthcare organizations to survive, data-driven management is needed. As payment reforms increase pressure to improve quality while lowering costs, some hospitals have adopted quality improvement methodologies from other industries, like data analytics. Experts believe healthcare providers that invest in analytics through partnerships will have success. The article outlines the types of data analytics used in healthcare - descriptive analytics of past data, predictive analytics to forecast future needs, and prescriptive analytics to provide recommendations. It also discusses challenges to implementing data-driven management and provides steps for healthcare organizations to become more data-driven.
This document discusses how life sciences companies can address challenges in the industry by adopting new technologies. It identifies trends putting pressure on companies, such as new regulations and shifting customer expectations. It then presents solutions that technology can provide: a new multi-channel commercial model to better engage customers; business agility through cloud-based platforms to accelerate innovation; and a focus on outcomes through data analytics and patient services to improve care. Adopting modern cloud technologies, the document argues, is key for companies to transform their business models and adapt to changes in the industry environment.
Providers need to move towards real-time analytics that have become critical to demonstrate their quality of care, as reimbursement by government programs can be contingent upon how providers are measured in “Quality of Care”. For example, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, also called the Permanent Doc Fix, changes the way Medicare doctors are reimbursed with the implementation of a merit based incentive. The performance-based pressure is huge, which makes it imperative that every provider consider technology solutions. Read more at https://www.solix.com/solutions/data-driven-solutions/healthcare/
This document provides an overview of Synergetics' "Industry in Focus" series highlighting trends in the healthcare and life sciences industry and how Synergetics is positioned to help clients in this sector. It discusses the challenges facing third party administrators in healthcare, including balancing costs and provider reimbursement rates. It also identifies factors driving increasing healthcare costs and provides examples of ways Synergetics has helped healthcare clients improve efficiency and profitability through process improvements and technology optimization.
Healthcare ito in healthcare payer - annual report - preview deck - july 2013Everest Group
This report provides an overview of the ITO market for the healthcare payer industry. Analysis includes key trends in market size & growth, demand drivers, adoption & scope trends, emerging themes, key areas of investment, and implications for key stakeholders. The report also provides specific updates on the readiness of the various stakeholders from the perspective of payer reform mandates
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiTTC, llc
The document discusses current challenges and future trends in clinical development from the perspective of a CRO. It notes that the global CRO market is large but fragmented, and outlines pressures on the pharmaceutical industry like high R&D costs, patent expirations, and regulatory demands. The text also examines trends towards more global, efficient trials using new technologies and less traditional geographies to address these challenges. It argues that collaboration between industry, regulators and CROs will be key to transforming clinical research methods.
In recent years, medical device manufacturers have embarked on an acquisition binge. We’ve seen a series of blockbuster deals as well as numerous smaller transactions. This M&A bonanza has been sparked in part by the belief that absolute scale creates competitive advantage.
But does it? In many other industries, we find a clear correlation between overall scale and profitability. Classic strategy has long focused on building scale because larger companies tend to wield more influence with customers and have a greater ability to maintain pricing discipline. They also benefit from the most accumulated experience with driving down costs and can spread costs over the widest base of business.
Yet in medtech, the correlation between industry scale and profitability is quite weak. Instead, Bain research shows that profitability is more a function of category leadership than overall scale.
Strategic Medical Affairs in pharma and medical devicesAnjan Banerjee
Strategic medical affairs in pharma and medical devices outlines key drivers influencing the growing role of medical affairs functions. Regulatory requirements, demand for local excellence, and the need for transparency are pushing medical activities to expand in areas like medical strategy, clinical operations, and regulatory submissions. Medical affairs contributes throughout the product lifecycle by collecting and disseminating knowledge to internal and external audiences, and can help integrate products into healthcare systems from drug development to reimbursement.
United States life sciences companies face numerous challenges in 2015 related to market changes, consolidation, pricing pressures, and health reform. Six key issues are highlighted: 1) Market reconfiguration and consolidation due to factors like expiring patents are driving the need for companies to reassess strategies and explore M&A opportunities. 2) Pricing pressures exist from government efforts to control costs and from health plans increasing efforts to reduce pharmaceutical costs. 3) Health reform is shifting the market to value-based care, requiring companies to demonstrate drugs' and devices' true value and economic impact compared to alternatives.
This document summarizes the key findings of a 2005 survey on healthcare supply chain management conducted by HFMA. The survey identified areas of high opportunity to reduce costs, including physician/clinical buy-in, IT investments, and value analysis. Respondents estimated they could reduce supply costs by an additional 2.5% annually by focusing on standardizing items and improving purchasing controls and physician involvement. While most hospitals have standardization initiatives, physician awareness remains low. The document discusses strategies for improving physician buy-in, such as ensuring transparency and a process for evaluating new products.
The Foundations of Success in Population Health ManagementHealth Catalyst
From hospital systems to large employers, organizations are increasingly taking on financial risk for the health of populations. Drivers of this trend include the update to the MSSP model, the recent CMS Primary Cares Initiative announcement, the increasing prevalence of the Medicare Advantage model, innovative partnerships in the self-insured employer space, and the proliferation of Medicaid ACOs. Yet while market pressures push organizations toward population risk, they don't necessarily help them succeed: most organizations are struggling to attain or sustain the dual imperatives of high-quality care and cost containment. A primary reason? Short-sighted and tactical approaches that don't provide the flexible data infrastructure and tools to adapt to emerging trends in population health—or to support short-term contractual requirements while building toward long-term success.
View this launch webinar to learn about Health Catalyst’s Population Health Foundations solution, a data and analytics-first starter set aimed at optimizing performance in value-based risk arrangements and providing the data ecosystem that will flex and adapt to complex needs of risk-bearing organizations. Solution services ensure that the strategic value of data is maximized to improve performance in risk contracts—and provide side-by-side subject matter expert partnership for establishing short- and long-term goals for population health management (PHM).
Built on Health Catalyst’s foundational technology and supported by the nationwide experience and perspective of its experts, the Population Health Foundations solution helps organizations leverage multiple data sources to understand their patient populations and create meaningful views of financial and clinical quality performance. As a starter set that organizations can build on based on their needs, the solution is designed to compensate for the known limitations of “black box” population health applications that fail to reveal the “why” of analytic insights and exacerbate the challenges of transforming quality, cost, and care. The Population Health Foundations solution delivers the essential analytic tools needed for success under value-based risk arrangements.
In these slides you can expect to:
- Review recent changes to the field of value-based care, and reactions and insights from the market
- Discover how the Population Health Foundations solution can act as a comprehensive, data-first analytics solution to support your population stratification and monitoring needs
- Understand how this solution functions as a foundational starter set for value-based care success, enabling clients to leverage all their data and other relevant population health tools
The document discusses a technology company called SA Ignite that provides software solutions to help healthcare organizations comply with value-based care programs. It describes the challenges providers face with new programs like MIPS that tie Medicare reimbursements to quality metrics. SA Ignite's platform automates and simplifies tracking, measuring, and reporting on clinical and financial performance required by these programs. The platform provides end-to-end support through predictive analytics and expert guidance, helping organizations adapt to the shift toward value-based care.
Life Sciences: Leveraging Customer Data for Commercial SuccessCognizant
The document discusses how life sciences companies need to leverage customer data through master data management solutions in order to succeed commercially in an evolving healthcare landscape. It describes how the healthcare buying process has become more complex with new stakeholders influencing decisions. An effective customer data strategy is critical for life sciences companies to maintain a 360-degree view of customers and address the changing dynamics. This requires solutions that consolidate data from multiple sources to provide insights that can optimize commercial activities like marketing and sales.
Life Sciences: Leveraging Customer Data for Commercial SuccessCognizant
As the healthcare buying process becomes increasingly complex, master data management solutions focused on customer relationships are critical for life sciences companies to excel.
in order to meet cost reduction targets, CMOs
* Share patient data across ecosystems
* Embed shared organizational intelligence
* Establish guidance for quality & cost within physician workflows
* Prepare physician leaders to create a culture of continual improvement
This document discusses how moving to a true cloud-based ERP system can help healthcare providers succeed by improving efficiency. It notes that digital transformation in healthcare is being driven by consumer demand for better experiences. While many providers have adopted some new technologies, successful digital transformation requires integrating across departments. The document argues that a cloud-based ERP can eliminate silos by providing real-time, centralized access to financial, HR, supply chain and other data. Key benefits mentioned include improved decision-making, better talent management, and increased productivity. Examples are provided of healthcare providers that have boosted efficiency and outcomes by implementing a cloud ERP system.
AI - The Next Frontier for Connected Pharmasambiswal
Big pharma has long been challenged with siloed data resulting from drug discovery information, clinical trial results and product marketing research stored separately in decade-old legacy systems. Thus, the pharmaceutical industry is ripe for the actionable insights offered by these advances to offset the growing costs of drug discovery while still meeting the demands of a value-based care model. It is time for a connected approach in the pharmaceutical industry.
Healthcare data and its impact upon the patient care decision process via accurate, real-time, reliable data from disparate sources is creating a digital health revolution. Data-driven healthcare is beginning to have a huge impact addressing the challenges of every provider, through efficient handling of huge volumes of patient care data.
Industry Insights Healthcare Information Technology - October 2016Duff & Phelps
This issue of Healthcare IT Services Insights details the impact credentialing, privileging and enrollment has on the revenue cycle, providers and patients. Practitioner credentialing, used broadly here to include privileging and enrollment, is an often overlooked but increasingly critical process at the front end of revenue cycle management.
Payers are being challenged as the industry shifts from volume-based care to a value-based reimbursement structure that would benefit the patient, the healthcare provider and the payer. New payment models including fee-for-service only and pay-for performance creates impetus for payers to acquire, aggregate, and analyze data.
High Flyer Health IT Investments and Health IT Investment TrendsPlatform Houston
This document discusses trends in the healthcare IT industry, focusing on the transition from fee-for-service "volume" models to "value-based" models that emphasize quality and efficiency. It notes that the HITECH and ACA laws have laid the groundwork for this transition. Value-based models like Accountable Care Organizations are now impacting 10% of patients. The document also profiles three high-growth companies in areas like patient engagement, big data analytics, and remote care that are aligned with this transition.
This document discusses trends in the healthcare IT industry, focusing on the transition from fee-for-service "volume" models to "value-based" models that emphasize quality and efficiency. It notes that the HITECH and ACA laws have laid the groundwork for this transition. Value-based models like Accountable Care Organizations are now impacting 10% of patients. The document also profiles three high-growth companies in areas like patient engagement, big data analytics, and remote care that are aligned with this transition.
This document discusses 6 key trends in healthcare: 1) Shift to value-based payment models, 2) Deinstitutionalization of care moving to lower-cost settings, 3) Increased focus on care management and wellness, 4) Growth of the Medicare Advantage market, 5) Adoption of data-driven decision making, and 6) Digital health transformation. It provides examples of how healthcare payors and providers are responding to these trends through strategies like bundled payments, telemedicine, predictive analytics, acquisitions, modern data platforms, and digital solutions to improve the patient and provider experience.
Population Health Management Market Growth, Demand and Challenges of the Key ...IMARC Group
The global population health management market size reached US$ 60.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 194.3 Billion by 2028, exhibiting a growth rate (CAGR) of 19.2% during 2023-2028.
More Info:- https://www.imarcgroup.com/population-health-management-market
This document discusses a technology leadership award given to 3M for its clinical documentation improvement (CDI) solution, the 3M 360 Encompass System. It describes the industry challenges around clinical documentation that CDI aims to address. It then highlights how the 3M 360 Encompass System provides a unified platform that integrates computer-assisted coding, CDI, and analytics to help healthcare organizations improve documentation and coding processes. The system was an early leader in the market and has over 80% of the computer-assisted coding market share.
This document discusses a technology leadership award given to 3M for its clinical documentation improvement (CDI) solution, the 3M 360 Encompass System. It describes the industry challenges around clinical documentation that CDI aims to address. It highlights how the 3M 360 Encompass System provides a unified platform that integrates computer-assisted coding, CDI, and analytics to help healthcare providers improve documentation and coding. The system was an early leader in the market and has over 2,000 hospital customers, demonstrating its effectiveness in addressing the documentation challenges of ICD-10 implementation.
Vertical market expansion hc gleikin2013q4campaignGary Leikin
This document provides an overview of vertical market expansion and opportunities in the healthcare technology market. It discusses why companies pursue vertical market expansion, best practices for evaluating opportunities, and risks to avoid. The document analyzes the healthcare industry and trends driving changes, such as a shift to value-based care and managing chronic diseases. It also examines economic factors like the importance of outcomes and return on investment for new technologies. Finally, the document discusses enabling technologies from other industries that could drive advances in medical technology if applied to healthcare challenges.
Dr. Hemanth is a healthcare IT consultant with experience designing, integrating, and implementing various healthcare solutions including EHR systems, patient portals, quality reporting, population health analytics, and care coordination. As a clinician, he is passionate about creating IT solutions that help providers focus on patient care amid changing regulations. He has successfully delivered solutions across multiple product lines for healthcare organizations.
ComplianceQuest provides a cloud-based enterprise quality management system that offers several benefits:
1) It translates next-generation technologies like mobility, AI and ML into unrivaled customer value.
2) The system facilitates quality management across the entire value chain from sourcing to manufacturing to the supply chain.
3) ComplianceQuest prioritizes customer satisfaction throughout the solution lifecycle with rapid implementation and flexible solutions.
Flex is a global contract manufacturer that was named Company of the Year for Medical Device Design and Manufacturing Solutions by Frost & Sullivan in 2019. Flex partners with healthcare companies to design and manufacture innovative medical devices by leveraging its expertise in electronics and manufacturing. Flex helps companies bring products to market faster through its "sketch-to-scale" approach and ensures products remain technologically advanced. Flex also developed BrightInsight, an FDA and HIPAA-compliant platform that uses AI to integrate patient data and provide insights to support digital health.
Guardhat was founded in 2014 to address the lack of safety solutions for industrial workers. It has developed an end-to-end system using proprietary hardware and software to provide comprehensive situational awareness and connectivity. This includes real-time location tracking of workers and assets, two-way communication capabilities, and integration of sensor data. Guardhat's KYRA platform combines data from different sources into a single analytics engine and control center, allowing customers to view all information in a unified way. The system aims to improve safety, productivity, and unlock potential big data insights.
Siemens Healthineers received Frost & Sullivan's 2019 Visionary Innovation Leadership Award for precision imaging. The document discusses 4 pillars of Siemens' precision imaging efforts: 1) Improved diagnostic accuracy through advances in imaging equipment, IT, and informatics. 2) Reducing variability through technologies like motion sensors to standardize imaging results. 3) Integrating diverse patient data like genomics and medical records to personalize treatment. 4) Advancing therapies like image-guided procedures through technologies like wide-space C-arm systems. Frost & Sullivan recognizes Siemens for taking a holistic approach across its portfolio to establish imaging's role in precision medicine.
The document discusses Proofpoint being recognized with the Frost & Sullivan 2019 Market Leadership Award for Email Security - Global. It outlines the challenges in the email security industry, including the continued use of email for threats and attacks. It describes Proofpoint's market leading position in email security, with over 21.8% market share in 2017. The summary highlights Proofpoint's comprehensive cloud-based email security solution and its focus on the enterprise segment through people-centric security and growth in areas like Office 365 integration.
This document provides an overview of Proofpoint's Frost & Sullivan Best Practices Award for Product Line Strategy Leadership in 2019 for its Security Awareness Training solutions in Europe. It discusses the challenges in the security awareness industry, highlights how Proofpoint addresses these challenges through an integrated people and technology approach, and provides concise descriptions of Proofpoint's product breadth, technology leverage capabilities, and customizable features.
The document summarizes Frost & Sullivan's 2018 New Product Innovation Award given to WENZEL Group GmbH & Co. KG for its SF 87 shop floor coordinate measuring machine (CMM). The SF 87 addresses key industry challenges by offering a larger measurement volume with a smaller footprint compared to competitors, as well as a wider operating temperature range suitable for shop floors. It also seamlessly integrates with material handling solutions. This positions the SF 87 well to help customers shift from offline to inline inspections. With its innovative product and commitment to customer value, WENZEL is poised to become a disruptor and global innovation leader in the CMM industry.
Intermedia's cloud communications and collaboration solution, Intermedia Unite, provides SMBs with a comprehensive set of features along with easy management and strong reliability. It offers cloud PBX, conferencing, file sharing and backup in one package. The solution is designed to be intuitive for SMBs without dedicated IT. Intermedia backs its service with a financially backed SLA of 99.999% uptime, exceeding competitors. By prioritizing features, ease of use, and reliability, Intermedia delivers superior value to SMB customers.
Cisco holds the leading market share in the global network firewall market at nearly 19%. Cisco has grown its market share faster than competitors due to its effective growth strategy and strong brand in security. Cisco's strategy includes a suite of firewall product lines to meet the needs of different market segments, as well as threat intelligence from Cisco Talos. Cisco's expanding portfolio of security products and services strengthens its brand and justifies investment in its firewall lines.
GenCell provides affordable fuel cell solutions as an alternative to diesel generators. By using alkaline electrolyte instead of platinum, GenCell reduces costs while maintaining high efficiency of 60% for its alkaline fuel cells. GenCell's solutions include the G5 for long-duration backup power, the G5rx tailored for utility needs, and the A5 for off-grid areas. The A5 runs on ammonia and has much lower operating costs than diesel generators, enabling reliable power anywhere. By removing expensive materials like platinum, GenCell makes fuel cell technology affordable and suitable for widespread use.
Huawei's smart site telecom energy solution provides unprecedented customer value through its use of artificial intelligence and advanced analytics. The solution optimizes site operations by analyzing data from smart components to improve efficiency, reduce costs, and enhance the customer experience. Huawei's innovation and customer-focused approach positions it for continued growth and leadership in the telecom energy market.
This document discusses NanoXplore Inc., a graphene manufacturing company. It summarizes that NanoXplore has developed a proprietary process for producing high-quality graphene from natural graphite at low cost. This scalable process allows them to produce large quantities of graphene at a more affordable price than competitors. NanoXplore uses its graphene to enhance the properties of various materials and has many customers across industries. It is building the largest graphene production facility in the world, which will further reduce costs and allow wider adoption of the material. For these innovations, NanoXplore has received the 2018 Frost & Sullivan Technology Innovation Award.
ZF Friedrichshafen AG (ZF Group) has been recognized as the 2018 European Automotive Aftermarket Company of the Year by Frost & Sullivan for its visionary innovation and strong performance in addressing industry challenges. ZF leverages its global leadership in automotive technology to position itself for future growth in the aftermarket through brands like LEMFÖRDER, SACHS, and TRW. It supplies a wide range of parts and focuses on emerging areas like electric vehicles and autonomous driving to adapt to changing market trends.
The document discusses Kgroup being awarded the 2018 European Commercial Refrigeration Company of the Year Award by Frost & Sullivan. It highlights Kgroup's visionary innovation through its extensive product portfolio that addresses customer needs, its use of mega trends to develop futuristic solutions, and excellence in implementing strategies. Examples provided include Kgroup's new full vision doors that enhance the user experience and energy savings, as well as its modular product design that optimizes transportation costs. The award recognizes Kgroup's leadership in commercial refrigeration through innovative products that deliver excellent price and performance value for customers.
INTEGRA Biosciences was recognized as the 2018 Global Company of the Year for laboratory pipetting. The document highlights INTEGRA's innovative pipetting solutions that address unmet needs like trouble-free tip pickup, rapid volume adjustment, reformatting workflows efficiently, and providing high throughput automation at low cost. INTEGRA implements best practices through a direct sales force, broad product range, and strong brand reputation for usability and performance.
Zonar Systems was recognized as the 2018 North American School and Transit Bus Telematics Company of the Year for addressing key industry challenges through innovative solutions. Zonar provides fleet management technology including GPS tracking, electronic inspection reporting, and ELD-ready solutions. Their solutions help customers improve safety, reduce costs through improved efficiency, and meet increasingly strict emissions regulations. Zonar has achieved significant customer impact with a 99% retention rate by providing strong customer support.
Perstorp received the 2018 European Bio-based Materials Product Leadership Award for its innovative renewable polyol products and commitment to sustainability. The company developed three partially renewable polyol products - Voxtar, Evyron, and Neeture - that contain varying percentages of renewable raw materials from 20-100% to help customers lower their carbon footprint. Perstorp allocates over 80% of its R&D resources to developing sustainable solutions, and aims to significantly reduce its carbon footprint by switching to renewable resources and recycling. It maintains a strong customer-centric approach by allowing gradual transitions to renewable materials while ensuring high product quality and performance.
The document discusses Martello Technologies, a company that provides network optimization and performance management solutions. It acquired Elfiq Networks in 2018 to strengthen its ability to offer an innovative solution for unified communications network and application performance management. The combination of Martello's network performance software and Elfiq's SD-WAN technology allows for end-to-end network visibility and troubleshooting of real-time service issues through optimized bandwidth allocation. This provides an unprecedented quality of experience for customers.
Cisco has achieved market leadership in the network access control (NAC) market with 34.3% market share. Cisco's NAC solution, Identity Services Engine (ISE), provides comprehensive visibility, policy control, and integration capabilities. ISE scales to support large enterprises and can profile and control access for a wide range of devices. Cisco has over 29,000 ISE customers and is focused on innovation, partnerships, and addressing customer needs across industries to maintain its leadership position in the growing NAC market.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.